Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardioEd #Cardiology https://t.co/QrqckPozvI
Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2022 – Jun 2025Where it's discussed
-
X / Twitter207 posts
-
News4 articles
-
Blogs2 articles
-
YouTube1 videos
AI synopsis
What people are saying
Several discussions highlight key aspects of managing hypertrophic cardiomyopathy, emphasizing surgical options and risk stratification. The use of terms like 'essential insights' and 'crucial recommendations' strongly indicates a high level of interest and perceived impact of the article, showcasing how the language used fosters a sense of urgency and appreciation within the community.
Many discussions echo a shared acknowledgment of the findings presented in the article.
Participants express strong enthusiasm for the content, indicating it is a hot topic within the medical community.
While the depth of engagement varies, some posts reference specific management insights, indicating a thoughtful consideration of the study.
Overall sentiment reflects a belief that this publication will significantly influence clinical practice and patient management strategies.
Abstract in brief
- Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease that is now highly treatable, with various options available for patients of all ages.
- HCM patients can benefit from advanced risk stratification for preventive measures, surgical options to alleviate heart failure, and treatments to reduce stroke risk and arrhythmia episodes, greatly improving patient outcomes and reducing mortality.
- Some patients with mild symptoms may not require major interventions, and expert reviews provide valuable recommendations for managing HCM effectively.
Top posts
Most liked on X and BlueskyJAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn7f5mEb
後で読むフォルダに入れてあたためていた 先月のJACC
Surgery in obstructive Hypertrophyc Cardiomyopathy - #echofirst #3DEcho MPR (Multi-slice) @DICSBC @ASE360 @DICSBC @SociedadeRio @JACCJournals @Cardiov54929315 https://t.co/rDiuSn9pbT https://t.co/RiuaH2L2MM https://t.co/UQpDRTkUYy
@GARCIAEDINSON95 Looks like https://t.co/YSQfkZZCsZ
All mentions
Understanding Hypertrophic Cardiomyopathy and Its Management
This video reviews hypertrophic cardiomyopathy (HCM), an inherited heart disease that is highly treatable. It covers diagnostic imaging like ECG and MRI, different subtypes, and medications including beta blockers and a…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @masiqueirajr: Surgery in obstructive Hypertrophyc Cardiomyopathy - #echofirst #3DEcho MPR (Multi-slice) @DICSBC @ASE360 @DICSBC @Socied…
RT @masiqueirajr: Surgery in obstructive Hypertrophyc Cardiomyopathy - #echofirst #3DEcho MPR (Multi-slice) @DICSBC @ASE360 @DICSBC @Socied…
Surgery in obstructive Hypertrophyc Cardiomyopathy - #echofirst #3DEcho MPR (Multi-slice) @DICSBC @ASE360 @DICSBC @SociedadeRio @JACCJournals @Cardiov54929315 https://t.co/rDiuSn9pbT https://t.co/RiuaH2L2MM https://t.co/UQpDRTkUYy
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review | Journal of the American College of Cardiology https://t.co/ZW4UaqsR8A
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
https://t.co/gGerewRkCu
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
RT @ZHeart11768530: Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardio…
Management of Hypertrophic Cardiomyopathy: #JACC State-of-the-Art Review https://t.co/c9p7zSioof #CardioTwitter #cardioEd #Cardiology https://t.co/QrqckPozvI
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
RT @MHcsba: JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn…
JAC State of the Art 2022: Manejo de miocardiopatía hipertrófica #MedEd #MedTwitter https://t.co/6p4kUecfCf https://t.co/hpFn7f5mEb
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @javier20ch: Manejo de la miocardiopatia hipertrófica.
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @Zill_cardio: Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review with management insights and recommendations for c…
RT @MarcKatzMD: @GARCIAEDINSON95 Looks like https://t.co/YSQfkZZCsZ
RT @MarcKatzMD: @GARCIAEDINSON95 Looks like https://t.co/YSQfkZZCsZ
@GARCIAEDINSON95 Looks like https://t.co/YSQfkZZCsZ
RT @misako_desu: 後で読むフォルダに入れてあたためていた 先月のJACC
後で読むフォルダに入れてあたためていた 先月のJACC
Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review https://t.co/I9gWgDQh8T